NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/12/2018
Back to search
Official data from USPTO
MEDIXMAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDIXMAB
ST13
US500000078862953Class
1, 5, 10
Filing
78862953
Registration
3381878
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
04/12/2018
Trademark type
Word
Nice classes
1, 5, 10
Filing date
04/17/2006
Registration date
02/12/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2018
Last transaction
04/12/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
09
Owner location
Espoo, FI
Examiner
BRADLEY, EVELYN
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Oy Medix Biochemica Ab
Oy Medix Biochemica Ab
Representatives
Roger H. Bora THOMPSON HINE LLP
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for medical research; reagent media for medical research
Class 5
Diagnostic preparations for medical use; reagent media for medical purposes; in vitro test kits for medical and clinical use consisting primarily of reagents and processing chemicals
Class 10
Diagnostic testing apparatus and instruments for medical usedetectors and analyzers for use in vitro diagnostic testing procedures; medical diagnostic tests kits for professional or home use comprised of collection pads or swabscollection loops or vialstest strips capable of visual or instrument read out of test results and/or vials of developer solution or reagentswhich use oral fluidfinger stick or venipuncture whole bloodplasmaserumother bodily fluids and specimens for use in detecting antibodiesantigenvirusesdiseasesnucleic acidspathogensproteinstoxins and chemicals
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/12/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/12/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
04/10/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/12/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/26/2014
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/26/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/26/2014
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
02/11/2014
E815
TEAS SECTION 8 & 15 RECEIVED
02/11/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
02/12/2008
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/08/2008
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/08/2008
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
12/19/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/04/2007
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
10/19/2007
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/05/2007
PUBO
PUBLISHED FOR OPPOSITION
06/05/2007
NPUB
NOTICE OF PUBLICATION
05/16/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/05/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/04/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2007
ALIE
ASSIGNED TO LIE
04/03/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/27/2007
GNRT
NON-FINAL ACTION E-MAILED
09/22/2006
CNRT
NON-FINAL ACTION WRITTEN
09/22/2006
DOCK
ASSIGNED TO EXAMINER
09/22/2006
NWAP
NEW APPLICATION ENTERED
04/21/2006
Continuous trademark protection
Get notified about every new filing that threatens MEDIXMAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.